ARS Pharmaceuticals SPRY
NASDAQ SPRY
$4.14 +0.03 (+0.61%)
As of: Oct 2, 2026 · 10:17 AM EDT

ARS Pharmaceuticals (SPRY) EV to FCF (2022 - 2024)

Updated

ARS Pharmaceuticals' (SPRY) EV to FCF stood at 55.40 in Q4 2024.

Analysis

ARS Pharmaceuticals (SPRY) EV to FCF (2022 - 2024) Analysis & Trends

  • The Q4 2024 figure is the lowest quarterly EV to FCF since Q3 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 ARS Pharmaceuticals 428.58 Mn 284.78 Mn 20.81 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 55.40
Sep 30, 2022 -8.57
API Access

ARS Pharmaceuticals EV to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=SPRY&period=max&api_key=YOUR_API_KEY